| Item Type | Name |
|
Concept
|
Prognosis
|
|
Academic Article
|
Molecular alterations in lung cancer. Impact on prognosis.
|
|
Academic Article
|
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
|
|
Academic Article
|
Lung carcinoma in African Americans.
|
|
Academic Article
|
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
|
|
Academic Article
|
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity.
|
|
Academic Article
|
Ethnic differences and functional analysis of MET mutations in lung cancer.
|
|
Academic Article
|
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
|
|
Academic Article
|
The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
|
|
Academic Article
|
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
|
|
Academic Article
|
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
|
|
Academic Article
|
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer.
|
|
Academic Article
|
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
|
|
Academic Article
|
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
|
|
Academic Article
|
Personalized treatment of lung cancer.
|
|
Academic Article
|
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
|
|
Academic Article
|
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
|
|
Academic Article
|
Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
|
|
Academic Article
|
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
|
|
Academic Article
|
Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosis.
|
|
Academic Article
|
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA.
|
|
Academic Article
|
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
|
|
Academic Article
|
Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
|
|
Academic Article
|
A new PET/CT volumetric prognostic index for non-small cell lung cancer.
|
|
Academic Article
|
Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
|
|
Academic Article
|
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.
|
|
Academic Article
|
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
|
|
Academic Article
|
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
|
|
Academic Article
|
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.
|
|
Academic Article
|
Early mortality of stage IV non-small cell lung cancer in the United States.
|
|
Academic Article
|
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.
|
|
Academic Article
|
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
|
|
Academic Article
|
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors.
|
|
Academic Article
|
Therapeutic targeting of miRNA-216b in cancer.
|
|
Academic Article
|
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
|
|
Academic Article
|
Disparate outcomes in nonsmall cell lung cancer by immigration status.
|
|
Academic Article
|
Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer.
|
|
Academic Article
|
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics.
|
|
Academic Article
|
Prognostic significance of natural products against multidrug tumor resistance.
|
|
Academic Article
|
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma.
|
|
Grant
|
Role of c-Met in SCLC and Potential for Novel Therapy
|
|
Grant
|
Novel Targeted Therapy in Pancreatic Cancer
|